June 5, 2017
Cermaq's sustainability performance in the first quarter (January-March) of this year shows strong performance on social indicators in all regions whereas the performance on fish health and environment reflects the local operational challenges in each region.
The fish survival rate measured as 12 months rolling rate was highest in Norway with 94.8 % and between 92-93% in Canada and Chile for Atlantic salmon.
In Canada, the treatment for sea lice in feed was at the same level as previous year. In Chile, there was an increase in bath treatment, whereas there were no bath treatments in Norway (including hydrogenperoxide).
The use of Cleaner fish has proven effective in the Norwegian operations and Cermaq is engaged in research into local cleaner fish in Canada.
Through an industry wide initiative in Chile, a native Cleaner fish species (Malapterus reticulatus) has been identified and Cermaq Chile will start breeding trials.
Cermaq is testing the effect of Imvixa at its research site in Chile. Imvixa is a new oral treatment against sea lice which has been approved in Chile. At this point, it seems to have a significant effect on Caligus sea lice. Still, it is too early to draw conclusions, Cermaq states.
Cermaq achieved new ACS certifications in all regions and has, as of today, 25 ASC certified salmon farms.